- ISIN DE000A37FT41
- Country Deutschland
Upcoming Webcasts
Past Webcasts
Latest News
News Functions
Additional Functions
29 July 2024
Epigenomics AG
22 July 2024
Epigenomics AG
Epigenomics AG: Vorläufiges Halbjahresergebnis zum 30. Juni 2024
18 July 2024
Epigenomics AG
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
30 April 2024
Epigenomics AG
Epigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024
10 April 2024
Epigenomics AG
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
14 March 2024
Epigenomics AG
Epigenomics AG publishes financial results for fiscal year 2023
Upcoming Events
Latest Reports
News Functions
Additional Functions
14 March 2024
Epigenomics AG
Jahresabschluss 2023
10 August 2023
Epigenomics AG
Halbjahresfinanzbericht 2023
31 May 2023
Epigenomics AG
Q1 statement / Q1 financial report 2023
28 April 2023
Epigenomics AG
Jahresfinanzbericht 2022
Epigenomics AG
Annual financial report 2022
Latest Research
News Functions
Additional Functions
25 August 2020
Epigenomics AG
Original-Research: Epigenomics AG (von First Berlin Equity Research GmbH): Kaufen
16 April 2018
Epigenomics AG
Original-Research: Epigenomics AG (von First Berlin Equity Research GmbH): Buy
19 December 2017
Epigenomics AG
Original-Research: Epigenomics AG (von First Berlin Equity Research GmbH): BUY
6 October 2017
Epigenomics AG
Original-Research: Epigenomics AG (von First Berlin Equity Research GmbH): BUY
21 April 2011
Epigenomics AG
Original-Research: Epigenomics AG (von MIDAS Research): Langfr. Kaufen
15 November 2010
Epigenomics AG
Original-Research: Epigenomics AG (von MIDAS Research): Langfristig Kaufen